DEAD

Serial Number

90879588

Owner

Teva Pharmaceuticals USA, Inc.

Attorney

Laurence Rickles

First Use Date

Jan 1, 2024

Filing Date

Aug 12, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SIMLANDI (ADALIMUMAB-XXXX) INJECTION Trademark

Serial Number: 90879588

SIMLANDI (ADALIMUMAB-XXXX) INJECTION is a trademark filed by Teva Pharmaceuticals USA, Inc. on August 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (588 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Legal Representation

Attorney of Record

Laurence Rickles

292 trademarks filed View all →

Correspondence Address

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

400 INTERPACE PARKWAY

BUILDING A

PARSIPPANY, NJ 07054

United States

Trademark Details

Filing Date

August 12, 2021

Registration Date

Not Registered

First Use Anywhere

January 1, 2024

First Use in Commerce

January 1, 2024

Published for Opposition

January 18, 2022

Goods & Services

Pharmaceutical preparations featuring monoclonal antibodies for the treatment of autoimmune diseases

Injectors for medical purposes, namely, medical fluid injectors

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Feb 21, 2025 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Feb 21, 2025 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 4, 2024 GNRN

NON-FINAL ACTION E-MAILED

Nov 4, 2024 GNRT

SU - NON-FINAL ACTION - WRITTEN

Nov 4, 2024 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Nov 1, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 1, 2024 AITU

USE AMENDMENT FILED

Aug 30, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 30, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 14, 2024 EXRA

SOU EXTENSION 4 GRANTED

Mar 13, 2024 EX4G

SOU EXTENSION 4 FILED

Mar 13, 2024 EXT4

SOU TEAS EXTENSION RECEIVED

Mar 13, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 14, 2023 EXRA

SOU EXTENSION 3 GRANTED

Sep 12, 2023 EX3G

SOU EXTENSION 3 FILED

Sep 12, 2023 EXT3

SOU TEAS EXTENSION RECEIVED

Sep 12, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 8, 2023 EXRA

SOU EXTENSION 2 GRANTED

Mar 6, 2023 EX2G

SOU EXTENSION 2 FILED

Mar 6, 2023 EXT2

SOU TEAS EXTENSION RECEIVED

Mar 6, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 17, 2022 EXRA

SOU EXTENSION 1 GRANTED

Sep 15, 2022 EX1G

SOU EXTENSION 1 FILED

Sep 15, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Sep 15, 2022 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 15, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 18, 2022 NPUB

PUBLISHED FOR OPPOSITION

Jan 18, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 29, 2021 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 11, 2021 PREV

ASSIGNED TO LIE

Dec 10, 2021 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 8, 2021 CNSA

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Dec 7, 2021 ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Nov 30, 2021 PBCR

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 18, 2021 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 18, 2021 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 18, 2021 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 18, 2021 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 18, 2021 CNEA

ASSIGNED TO EXAMINER

Nov 12, 2021 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 5, 2021 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 4, 2021 NWOS

NEW APPLICATION ENTERED

Aug 16, 2021 NWAP

Related Trademarks

More from this Owner

More in Same Class

P P P EROTIC JUSTICE !

AFLOFARM